These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 7874760)
1. [Comparative study of the expression of IGF-2 and HBxAg in human hepatocellular carcinoma and liver cirrhosis]. Zhang JF; Liu YF; Su Q Zhonghua Bing Li Xue Za Zhi; 1994 Oct; 23(5):282-4. PubMed ID: 7874760 [TBL] [Abstract][Full Text] [Related]
2. Lack of colocalization of HBxAg and insulin like growth factor II in the livers of patients with chronic hepatitis B, cirrhosis and hepatocellular carcinoma. Seo JH; Kim KW; Murakami S; Park BC J Korean Med Sci; 1997 Dec; 12(6):523-31. PubMed ID: 9443091 [TBL] [Abstract][Full Text] [Related]
3. Expression of insulin-like growth factor II in chronic hepatitis B, liver cirrhosis, and hepatocellular carcinoma. Seo JH; Park BC Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():292-307. PubMed ID: 7661600 [TBL] [Abstract][Full Text] [Related]
4. [Immunohistochemical study of hepatitis C virus core antigen and HBxAg in liver cirrhosis and hepatocellular carcinoma tissues]. Wang C; Wang W; Lu H Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):85-8. PubMed ID: 10743066 [TBL] [Abstract][Full Text] [Related]
5. [A study of the relationship between expression of IGF-II, IGF-IIR, HBxAg and the DNA ploidy, cell cycle of hepatocytes in hepatocarcinoma]. Deng T; Chen NL; Jia KM Zhonghua Nei Ke Za Zhi; 1994 Nov; 33(11):743-6. PubMed ID: 7600862 [TBL] [Abstract][Full Text] [Related]
6. [Preparation of monoclonal antibody directed against hepatitis B virus X protein and detection of reactive antigen in hepatocellular carcinoma]. Li J; Tang ZY; Liu KD; Schroder CH Zhonghua Yi Xue Za Zhi; 1994 Sep; 74(9):533-5, 582. PubMed ID: 7842349 [TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemical study on X antigen of HBV (HBxAg) in primary hepatic carcinoma]. Wang WL Zhonghua Zhong Liu Za Zhi; 1992 Sep; 14(5):331-3. PubMed ID: 1337887 [TBL] [Abstract][Full Text] [Related]
8. Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression. Su Q; Liu YF; Zhang JF; Zhang SX; Li DF; Yang JJ Hepatology; 1994 Oct; 20(4 Pt 1):788-99. PubMed ID: 7927218 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer. Wang WL; London WT; Feitelson MA Cancer Res; 1991 Sep; 51(18):4971-7. PubMed ID: 1654208 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical assessment and prognostic value of hepatitis B virus X protein in chronic hepatitis and primary hepatocellular carcinomas using anti-HBxAg monoclonal antibody. Pál J; Somogyi C; Szmolenszky A A; Szekeres G; Sípos J; Hegedüs G; Martzinovits I; Molnár J; Németh P Pathol Oncol Res; 2001; 7(3):178-84. PubMed ID: 11692143 [TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma. A study of 50 autopsy cases with detection of hepatitis B surface antigen in fixed tissues. Perez-Barrios A; Colina-Ruizdelgado F; Gallego I; Martinez-Tello FJ Pathol Res Pract; 1983 Mar; 176(2-4):131-44. PubMed ID: 6190153 [TBL] [Abstract][Full Text] [Related]
12. [The effects of p38MAPK and HBxAg on cell proliferation and apoptosis in human hepatocarcinogenesis]. Shen LJ; Guo W; Gao P; Yu J; Qian ZY; Zhang HX; Zhang ZJ Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):227-30. PubMed ID: 22475145 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of HBxAg in hepatocellular carcinoma and its relationship with Fas/FasL system. Wang XZ; Chen XC; Chen YX; Zhang LJ; Li D; Chen FL; Chen ZX; Chen HY; Tao QM World J Gastroenterol; 2003 Dec; 9(12):2671-5. PubMed ID: 14669310 [TBL] [Abstract][Full Text] [Related]
14. The value of hepatitis B x antigen as a prognostic marker in the development of hepatocellular carcinoma. Zhu M; London WT; Duan LX; Feitelson MA Int J Cancer; 1993 Oct; 55(4):571-6. PubMed ID: 8406983 [TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-II is a useful marker to detect hepatocellular carcinoma? Morace C; Cucunato M; Bellerone R; De Caro G; Crinò S; Fortiguerra A; Spadaro F; Zirilli A; Alibrandi A; Consolo P; Luigiano C; Resta ML; Ferraù O; Spadaro A Eur J Intern Med; 2012 Sep; 23(6):e157-61. PubMed ID: 22863442 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of aflatoxin B1-DNA adducts and hepatitis B virus antigens in hepatocellular carcinoma and nontumorous liver tissue. Santella RM; Zhang YJ; Chen CJ; Hsieh LL; Lee CS; Haghighi B; Yang GY; Wang LW; Feitelson M Environ Health Perspect; 1993 Mar; 99():199-202. PubMed ID: 8391434 [TBL] [Abstract][Full Text] [Related]
17. Integrity of p53 in hepatitis B x antigen-positive and -negative hepatocellular carcinomas. Greenblatt MS; Feitelson MA; Zhu M; Bennett WP; Welsh JA; Jones R; Borkowski A; Harris CC Cancer Res; 1997 Feb; 57(3):426-32. PubMed ID: 9012469 [TBL] [Abstract][Full Text] [Related]
18. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma. Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206 [TBL] [Abstract][Full Text] [Related]
19. [Expression and significance of Pre-S1 and Pre-S2 in human primary hepatic carcinoma (PHC)]. Wang WL Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):83-6. PubMed ID: 1319893 [TBL] [Abstract][Full Text] [Related]
20. [Expression of five different antigens of HBV in human intrahepatic cholangiocarcinoma and cholangiohepatocarcinoma]. Wang WL Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):252-5. PubMed ID: 8174460 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]